| Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773) |
|---|
| 04/22/2008 | US7361677 Polycyclic sulphamate compounds suitable for use as inhibitors of aromatase and/or sulphatase |
| 04/22/2008 | US7361671 E.g.,(6-Ethyl-3-(4,5,7-trifluoro-benzothiazol-2-ylmethyl)-pyrr (2,3-b)pyridin-1-yl)acetic acid; interacts with and inhibits aldose reductase; antidiabetic agents and diabetic complications; gout; hypoglycemic and antiarthritic |
| 04/22/2008 | US7361670 Amide derivatives as NMDA receptor antagonists |
| 04/22/2008 | US7361669 particularly useful for treating cardiovascular disease |
| 04/22/2008 | US7361665 For therapy of inflammatory disease, autoimmune disease, destructive bone disorder, proliferative disorder, infectious disease, neurodegenerative disease, allergy, reperfusion/ischemia in stroke, heart attack, hypoxia |
| 04/22/2008 | US7361658 2-acylaminothiazole derivative or salt thereof |
| 04/22/2008 | US7361657 Drugs for treatment of respiratory syncytial virus and salt formation |
| 04/22/2008 | US7361648 1-(4-{ethyl-[2-(4-methanesulfonylphenyl)-1-methylethyl]amino}butyl)-4-methanesulfonyl-[1,4]diazepan-2-one; repiratory system disorders: asthma and chronic obstructive pulmonary disease; nervous system, muscular,urogenital, gastrointestinal disorders; antiallergens; side effect reduction |
| 04/22/2008 | US7361449 Specific dye compound, optical information recording medium comprising specific dye, and information recording method using this optical information recording medium |
| 04/22/2008 | CA2400447C Kinase inhibitors |
| 04/22/2008 | CA2350137C New piperazine and di-dehydropiperidine compounds |
| 04/22/2008 | CA2210693C Pyrazol-4-yl-benzoyl derivatives and their use as herbicides |
| 04/17/2008 | WO2008045564A2 Carboxamide compounds and their use as antagonists of the chemokine ccr2 receptor |
| 04/17/2008 | WO2008045484A1 N-aryl pyrazole compounds for use against diabetes |
| 04/17/2008 | WO2008044777A1 2-pyridinecarboxamide derivative having gk-activating activity |
| 04/17/2008 | WO2008044700A1 GSK-3β INHIBITOR |
| 04/17/2008 | WO2008044095A1 Positively charged water-soluble prodrugs of oxicams and related compounds with very high skin penetration rate |
| 04/17/2008 | WO2008044022A1 Fused thiazole derivatives as kinase inhibitors |
| 04/17/2008 | WO2008043733A1 3- (benzo [d] [1,3] dioxol-5-ylmethyl) -4- (thio) oxo-2- (thio) oxo-azolidin-5-ylidene derivatives as antibacterial agents |
| 04/17/2008 | WO2008043544A1 Sulfonamide substituted pyrazoline compounds, their preparation and use as cb1 modulators |
| 04/17/2008 | WO2008024390A3 2- (pyrazin-2-yl) -thiazole and 2- (1h-pyraz0l-3-yl) -thiazole derivatives as well as related compounds as stearoyl-coa desaturase (scd) inhibitors for the treatment of metabolic, cardiovascular and other disorders |
| 04/17/2008 | WO2008024337A3 Compounds and methods for inhibiting the interaction of bcl proteins with binding partners |
| 04/17/2008 | WO2008017398A3 Polymorphic forms of rosiglitazone base |
| 04/17/2008 | WO2008011117A3 Antiviral protease inhibitors |
| 04/17/2008 | WO2008008887A3 Gpr119 agonists for treating metabolic disorders |
| 04/17/2008 | WO2008006625A3 Derivatives of urea and related diamines, methods for their manufacture, and uses therefor |
| 04/17/2008 | WO2008002571B1 Human protein tyrosine phosphatase inhibitors and methods of use |
| 04/17/2008 | WO2008002570B1 Human protein tyrosine phosphatase inhibitors and methods of use |
| 04/17/2008 | WO2007085895A3 Fap inhibitors |
| 04/17/2008 | US20080091025 Reduces the operating voltage and inhibits the molecules from being crystallized by using an aromatic amine derivative having a sulfur atom, an oxygen atom, a selenium atom, or a tellurium atom substituent for a hole transporting material; enhances yield in device, improves lifetime |
| 04/17/2008 | US20080091020 Polymorphic forms of ziprasidone HCI and processes for their preparation |
| 04/17/2008 | US20080091019 Crystalline form having X-Ray powder diffraction pattern with peaks at 9.4, 13.7, 14.5, 14.9, 18.1, 20.2, 22.8+-0.2 degrees 2 theta; reacting salt of ziprasidone with alkaline agent and precipitating |
| 04/17/2008 | US20080091018 Polymorphic form B2 of ziprasidone base |
| 04/17/2008 | US20080091017 Polymorphic form B2 of ziprasidone base |
| 04/17/2008 | US20080090996 Thrombopoietin mimetics |
| 04/17/2008 | US20080090891 Administering calcium channel modulators 2-(alkyl or (hetero)arylalkylthio)-imidazoles and S-oxides thereof; angina, hypertension, congestive heart failure, myocardial ischemia, arrhythmia, diabetes, urinary incontinence, stroke, pain, brain injury, or neuronal disorders |
| 04/17/2008 | US20080090846 Chemokine receptor binding heterocyclic compounds |
| 04/17/2008 | US20080090845 Haloalkyl-substituted pyrimidinone derivatives |
| 04/17/2008 | US20080090835 Polymorphic forms of ziprasidone HCl and processes for their preparation |
| 04/17/2008 | US20080090829 5-{2-[2-(4-Tert-Butyl- phenyl)-oxazol-4-yl]-ethylsulfamoyl}-2-methyl-benzoic acid methyl ester; used as peroxisome proliferator activator receptor agonist, to increase high density lipoproteins and lower LDL-cholesterol and triglycerides; treatment of atherosclerosis, cardiovascular, metabolic disorders |
| 04/17/2008 | US20080090828 insecticides for soil-borne insects, such as termites and white grubs; less costly and safer to use on crops; N-{4-[(4-{bis[4-(trifluoromethyl)phenyl]methylene}piperidyl)methyl]phenyl}ethoxycarboxamide, N-oxide |
| 04/17/2008 | US20080090823 Thiadiazoles as cxc- and cc- chemokine receptor ligands |
| 04/17/2008 | US20080090816 Anti-infective biaryl compounds |
| 04/17/2008 | US20080090815 Anticoagulates for treating cardiovascular disorders, such as myocardial infarct, angina pectoris, restenoses after angioplasty, bypass, stroke; treatment of atherosclerosis, arthritis, Alzheimer's disease or cancer |
| 04/17/2008 | US20080090814 For treating infections by hepatitis C virus; 4-(1,1-Dioxo-1,4-dihydro-1 lambda 6-benzo[1,4]thiazin-3-yl)-5-hydroxy-2-(3-methyl-butyl)-6-thiophen-2-yl-2H-pyridazin-3-one 16 |
| 04/17/2008 | US20080090807 Lactam-containing compounds and derivatives thereof as factor xa inhibitors |
| 04/17/2008 | US20080090805 Cb-1 modulating compounds and their use |
| 04/17/2008 | US20080090799 2-pyridinecarboxamide derivative having gk-activating effect |
| 04/17/2008 | US20080090797 tert-Butyl[3-(4-phenyloxazolidin-2-on-3-yl)-4-(2-styryl)azetidin-2-on-1-yl]acetate; known as synthetic intermediates for the preparation of beta -lactam antibiotics; diuretic |
| 04/17/2008 | US20080090787 Thrombopoietin mimetics |
| 04/17/2008 | US20080090782 Inhibit DNA-dependent protein kinase; reduced side effects caused by radiation and chemotherapy drugs |
| 04/17/2008 | DE102006048042A1 Acylaminoimidazole und Acylaminothiazole Acylaminoimidazole and Acylaminothiazole |
| 04/17/2008 | CA2675511A1 N-aryl pyrazole compounds for use against diabetes |
| 04/17/2008 | CA2666177A1 Acylaminoimidazoles and acylaminothiazoles |
| 04/16/2008 | EP1911755A1 Benzoimidazole compound capable of inhibiting prostaglandin d synthetase |
| 04/16/2008 | EP1911754A1 Dipeptidyl peptidase inhibitors |
| 04/16/2008 | EP1911747A1 Sulfonamide substituted pyrazoline compounds, their preparation and use as CB1 modulators |
| 04/16/2008 | EP1911740A1 Potassium channel modulators |
| 04/16/2008 | EP1911446A2 The use of PPAR-gamma agonists for treating diseases characterised by neuron degeneration, neuron injury or impaired plasticity |
| 04/16/2008 | EP1911350A1 Amidine compound and herbicide |
| 04/16/2008 | EP1910352A1 Heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| 04/16/2008 | EP1910351A1 Colourless water-soluble organic luminophores and intermediates thereof |
| 04/16/2008 | EP1910350A1 2 -heterocyclyloxybenzoyl amino heterocyclyl compounds as modulators of glucokinase for the treatment of type 2 diabetes |
| 04/16/2008 | EP1910349A1 2-arylbenzothiazoles and uses thereof |
| 04/16/2008 | EP1910348A2 Benzothiazole and azabenzothiazole compounds useful as kinase inhibitors |
| 04/16/2008 | EP1910347A2 Macrocylic inhibitors of hepatitis c virus |
| 04/16/2008 | EP1910342A1 Multicyclic sulfonamide compounds as inhibitors of histone deacetylase for the treatment of disease |
| 04/16/2008 | EP1910338A2 Heterotetracyclic compounds as tpo mimetics |
| 04/16/2008 | EP1910335A1 N-(heteroaryl)-1-heteroarylalkyl-1h-indole-2-carboxamide derivatives, preparation and use thereof |
| 04/16/2008 | EP1910330A1 Heterocyclylamide-substituted thiazoles, pyrroles and thiophenes |
| 04/16/2008 | EP1910321A1 New compounds, process for their preparation, intermediates, pharmaceutical compositions and their use in the treatment of 5-ht6 mediated disorders such as alzheimer's disease, cognitive disorders, cognitive impairment associated with schizophrenia, obesity and parkinson's disease |
| 04/16/2008 | EP1910294A1 A process for the preparation of substituted phenyl ether compounds and rosiglitazone |
| 04/16/2008 | EP1910285A1 Cyanopyrrole-sulfonamide progesterone receptor modulators and uses thereof |
| 04/16/2008 | EP1910284A1 Cyanopyrrole-phenyl amide progesterone receptor modulators and uses thereof |
| 04/16/2008 | EP1909792A1 Substituted piperidine derivatives as somatostatin sst1 receptor antagonists |
| 04/16/2008 | EP1909572A2 Potassium channel inhibitors |
| 04/16/2008 | EP1799690B1 Thiazolyl-dihydro indazoles |
| 04/16/2008 | CN101163697A Pyrrole derivatives as DNA gyrase and topoisomerase inhibitors |
| 04/16/2008 | CN101163696A Histone deacetylase inhibitors |
| 04/16/2008 | CN101163693A Antibacterial piperidine derivatives |
| 04/16/2008 | CN101163692A Heterocyclic substituted piperazines with cxcr3 antagonist activity |
| 04/16/2008 | CN100381937C Organophotoreceptor with charge transport material having a thiiranyl group |
| 04/16/2008 | CN100381936C Linked dihydrazone-based charge transport compounds |
| 04/16/2008 | CN100381566C Recombinant methods and materials for producing epothilone and eopthilone derivatives |
| 04/16/2008 | CN100381440C Inhibitors of serine proteases, particularly HCV NS3-NS4A protease |
| 04/16/2008 | CN100381438C New pyrrolidine and thiazolidine compounds, process for their preparation and pharmaceutical compositions containing them |
| 04/16/2008 | CN100381437C Compounds, compositions and methods |
| 04/16/2008 | CN100381429C Thiazole derivatives |
| 04/15/2008 | US7358386 Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation |
| 04/15/2008 | US7358376 Substituted Thiophene compounds |
| 04/15/2008 | US7358366 polymorphic form rosiglitazone maleate, used for prophylaxis of diabetes in humans; crystal structure |
| 04/15/2008 | US7358364 Substituted carboxylic acids |
| 04/15/2008 | US7358276 2-Oxo-1-pyrrolidine derivatives, processes for preparing them and their uses |
| 04/15/2008 | US7358268 Imidazole derivatives as factor Xa inhibitors |
| 04/15/2008 | US7358267 2-(pyrazol-1-yl)thiazole compounds; obesity and type II diabetes; modulators of the mitochondrial protein uncoupling protein 3 (UCP3); treating retinoid X receptor (RXR) modulated conditions; 2-(4-carboxy-5-methylpyrazol-1-yl)-4-(p-trifluoromethylphenyl)thiazole |
| 04/15/2008 | US7358266 Cyclopropyl and cyclobutyl epothilone analogs |
| 04/15/2008 | US7358263 Fused bicyclic-substituted amines as histamine-3 receptor ligands |
| 04/15/2008 | US7358257 sulfonylurea derivatives, sulfonylthiourea derivatives, sulfonylguanidine derivatives, sulfonylcyanoguanidine derivatives, thioacylsulfonamide derivatives, and acylsulfonamide derivatives; effective for prevention and treatment of cardiovascular diseases, antithrombotic agents |
| 04/15/2008 | US7358255 Use of 5-[4-(6-methoxy-1-methyl-1H-benzimidazol-2-ylmethoxy)benzyl] thiazolidine-2,4-dione |
| 04/15/2008 | US7358249 Heterocyclic compounds having inhibitory activity against HIV integrase |